This page will be updated on a monthly basis.
Travel and accommodation provided by Sanofi Diabetes to travel to Washington DC to be part of their FDA application team for sotagliflozin.
Honorarium £9750
Travel, accommodation and honorarium provided by Novo Nordisk to attend a Key Scientific Leaders meeting in Madrid.
Honorarium £2890
Travel and accommodation provided by Sanofi Diabetes to travel to New Jersey to be part of their FDA application team for sotagliflozin.
Honorarium £6500
Travel and accommodation provided by Sanofi Diabetes to travel to New Jersey to be part of their FDA application team for sotagliflozin.
Honorarium £7,250
Travel and accommodation provided by Sanofi Diabetes to travel to New Jersey to be part of their FDA application team for sotagliflozin.
Honorarium £7,250
Travel and accommodation provided by Sanofi Diabetes to travel to New Jersey to be part of their FDA application team for sotagliflozin.
Honorarium £7,250
Travel and accommodation provided by European Wound Management Association to speak at their annual conference, Krakow.
Travel and accommodation provided by Malvern Foot Conference to speak at their bi-annual conference, Malvern
Travel, accommodation and honorarium provided by Novo Nordisk to attend a Key Scientific Leaders meeting in Amsterdam.
Honorarium £5,500
Travel and accommodation provided by European Vascular Society to speak at the 22nd European Vascular Course, Maastricht.
Travel and accommodation provided by Dr Shashank Joshi to speak at the 17th International Symposium on Diabetes, Mumbai, India.
Travel and accommodation provided by Novo Nordisk to attend and present a poster at the International Diabetes Federation meeting in Abu Dhabi
Travel and accommodation provided by Sanofi Diabetes to attend an advisory board meeting in London.
Honorarium £1350
Travel, accommodation and honorarium provided by Novo Nordisk to attend a Key Scientific Leaders meeting in Berlin.
Travel and accommodation provided by Novo Nordisk to attend and present a poster at the European Association for the Study of Diabetes meeting in Lisbon
Chairing a meeting for Eli Lilly on GLP-1 analogue use
Honorarium £600
So far this year I have also met pharmaceutical reps in my office from:
Travel, accommodation and honorarium provided by Novo Nordisk to attend and speak at a Key Scientific Leaders meeting in Vienna.
Honorarium €4000
Travel, accommodation and honorarium provided by Novo Nordisk to attend a Key Scientific Leaders meeting in Barcelona.
Travel and honorarium to attend an internal event for Novo Nordisk for their Medical Affairs Leadership Academy.
Honorarium €750
Travel and Accommodation to a Pioneer 6 investigators meeting in Washington DC provided by Novo Nordisk
Travel for a meeting of the Joint British Diabetes Societies Inpatient Care Group to meet in London was funded by Diabetes UK
Travel, accommodation and honorarium provided by Novo Nordisk to attend and speak at a Key Scientific Leaders meeting in Paris
Honorarium £2000
Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Spring meeting of ABCD in Edinburgh.
Honorarium £250
Travel to speak at International Annual Scientific Meeting of the Association for Clinical Biochemistry and Laboratory Medicine in Warwick
I am on the clinical end point committee for Lexicon Pharmaceuticals on their trial on Sotagliflozin
Honorarium £50,000
Travel and honorarium to speak at the Specsavers Professional Advancement Conference, Oslo, Copenhagen and Stockholm.
Honorarium £3,750
Travel, accommodation and honorarium provided by Novo Nordisk to attend and speak at a Key Scientific Leaders meeting in Berlin
Honorarium £1,500
Travel to a research meeting provided by Novo Nordisk
Travel for a meeting of the Joint British Diabetes Societies Inpatient Care Group to meet in London was funded by Diabetes UK
I spoke at an evening meeting for GP’s and practice nurses sponsored by AstraZeneca in Norwich on why I would not recommend the use of SGLT-2 inhibitors
Honorarium £500
Spoke at the 20th annual Norfolk Respiratory Interest Group meeting, Norwich
Honorarium £250
Travel and accommodation to attend the 'Wound healing clinical development group' in Amsterdam provided by Genentech.
Honorarium £4,400
Travel and accommodation provided by Novo Nordisk to attend a Key Opinion Leaders meeting in Madrid.
Travel to attend National Audit of Inpatient Diabetes Advisory group and ABCD committee meeting provided by those groups.
Travel and accommodation to attend a Dulaglutide Speaker training session in Vienna provided by Lilly.
Honorarium £1250
Travel and honorarium to speak at the Specsavers Professional Advancement Conference, Birmingham.
Honorarium £500
Travel and honorarium to attend a research sub-study meeting for Sanofi-Aventis in Birmingham
Honorarium £2760
Travel and accommodation to San Francisco provided by Roche to attend a) the 5th meeting of the Blood Glucose Monitoring Performance Expert Panel and b) a round table meeting to meet with a team developing a new healing product for diabetic foot wounds at Genentech.
Honorarium $4000
Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Spring meeting of ABCD in Edinburgh. I am the meetings secretary and on their executive. I organise their meetings.
Travel and accommodation provided by Novo Nordisk to attend a Key Opinion Leaders meeting in London.
I spoke at an evening meeting for GP’s and practice nurses sponsored by Lilly and Boehringer Ingelheim in Great Yarmouth on Driving and Diabetes.
Honorarium £500
Travel provided by Diabetes UK to chair a session and speak at their national conference in Liverpool.
Travel and accommodation provided to attend the 2nd Joint meeting of the Association of British Clinical Diabetologists and the Renal Association provided by ABCD.
Travel costs to speak in London at the Royal Society of Medicine for the 3rd national diabetes inpatient conference, innovations in diabetes inpatient care provided by the RSM.
Costs for travel to speak in Dublin at their annual meeting provided by the Irish Orthopaedic Anaesthetists Association.
I was taken for a meal by the regional sales manager for Novo Nordisk
Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Autumn meeting of ABCD in London. I am the meetings secretary and on their executive. I organise their meetings.
Speaking at the Specialist Registrar meeting of the Association of British Clinical Diabeteologists (ABCD).
Honorarium £250
Travel to attend and speak at the Diabetes Inpatient Specialist Nurse UK Group meeting in London provided by the group.
Honorarium £100
Travel provided by the Cardio-renal forum for me to speak at their annual conference in London. The topic of my talk is: Do new diabetes drugs hold cardiovascular promise?
Honorarium £100
My travel and accommodation to the Heels Trial and the Leukopatch trial meeting in Birmingham were paid for by The HTA and Reapplix.
Travel and accommodation provided to attend the 3 day Diabetic Foot Study Group meeting in Sitges, Spain. Funding for this is from the research funds generated by the work done in the diabetic foot clinic I lead at the Norfolk and Norwich Hospital.
Travel to attend Joint British Diabetes Society steering group meeting in London provided by Diabetes UK.
Travel and accommodation provided to speak at the Jothydev Professional Educational Forum, Trivandrum, India by the Jothydev Diabetes Research Centre.
Honorarium of Rs 20,000 paid by P Jothydev Trust.
Also, to speak in Chennai, India on inpatient diabetes, travel and accommodation provided by Novo Nordisk (India).
No honorarium.
Travel and accommodation provided by Novo Nordisk to attend the 5 day American Diabetes Association meeting in Chicago.
Travel for a meeting of the Joint British Diabetes Societies Inpatient Care Group to meet in London was funded by Diabetes UK.
Travel for a meeting of the editorial board of Practical Diabetes in London was paid for by the journal.
Travel and accommodation provided by Novo Nordisk to attend a 2 day investigators meeting of the Leader Study in Prague. This is a phase 3b post marketing study comparing cardiovascular outcomes of people with diabetes and high risk of cardiovascular events given liraglutide vs placebo.
Travel and accommodation provided by Specsavers Finland to speak at their 1 day national Professional Advancement Conference in Helsinki. The topic of my lecture was: Diabetes related eye disease.
Honorarium €400
Travel and accommodation provided by Novo Nordisk to attend a 2 day ‘Key Scientific Leaders’ meeting in Madrid.
No honorarium.
Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Spring meeting of ABCD in Solihull. I am the meetings secretary and on their executive. I organise their meetings.
Travel provided by the Young Diabetologists Forum to speak at their national conference in Manchester. My lecture topic was: Peri-operative diabetes care.
No honorarium.
Travel provided by Diabetes UK to speak at their national conference in Manchester. My lecture topic was: JBDS Peri-operative Guidelines’ Impact on Elective Diabetes Care.
No honorarium.
I participated in an East Anglian Round Table meeting sponsored by Sanofi – Aventis discussing GLP–1 analogues, and Lixisenatide in particular.
Honorarium £400
Travel provided by Sanofi Aventis to teach at the one day Young Diabetologists Forum in Manchester. My lecture topic was: Peri-operative diabetes care.
No honorarium.
I spoke at a Practice Nurse seminar at Spire Norwich Hospital. The topic of my talk was: Diabetes, your questions answered.
My honorarium was a box of chocolates.
Travel and accommodation provided to attend a 2 day research meeting in Paris – sponsored by Urgo Laboratories, Paris. The foot clinic I lead at the Norfolk and Norwich Hospital is taking part in this multinational study examining the effect of a special wound dressing vs standard wound dressings
During 2015, I have met with representatives from the following companies, either in my office at the Norfolk and Norwich Hospital, or at local (L), national (N) or international (I) conferences.
During 2014, I have met with representatives from the following companies, either in my office at the Norfolk and Norwich Hospital, or at local (L), national (N) or international (I) conferences.
During 2013, I have met with representatives from the following companies, either in my office at the Norfolk and Norwich Hospital, or at local (L), national (N) or international (I) conferences
